# FDA Inspection 1083311 - AlloSource - February 26, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/allosource/74053353-c707-44d9-892e-f4ed72c3e7f2
Source feed: FDA_Inspections

> FDA Inspection 1083311 for AlloSource on February 26, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1083311
- Company Name: AlloSource
- Inspection Date: 2019-02-26
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1278944 - 2025-08-04](https://www.globalkeysolutions.net/records/fda_inspections/allosource/a891436a-6a93-4c0d-9a4d-c1ae62158dbb)
- [FDA Inspection 1278944 - 2025-08-04](https://www.globalkeysolutions.net/records/fda_inspections/allosource/ca5f26f3-640f-4459-80ae-a2e03dafef5a)
- [FDA Inspection 544221 - 2008-10-03](https://www.globalkeysolutions.net/records/fda_inspections/allosource/1ccd910f-695b-421b-a0f6-a9be6635faca)

Company: https://www.globalkeysolutions.net/companies/allosource/014c5d12-8d08-44d1-88ae-a7b76e12c2a0

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d